X-ray powder diffractometry in combination with principal component analysis - A tool for monitoring solid state changes

European Journal of Pharmaceutical Sciences

Volumn 43, Issue 4, 2011, Pages 278-289

  Kogermann, Karin ^a   Veski, Peep ^a   Rantanen, Jukka ^b   Naelapää, Kaisa ^b  

^a UNIVERSITY OF TARTU   (Estonia)

^b UNIVERSITY OF COPENHAGEN   (Denmark)

Author keywords

Amorphous; Piroxicam; Principal component analysis; Raman spectroscopy; Solid state phase transformations; X ray diffractometry

Indexed keywords

PIROXICAM;

ARTICLE; COOLING; CRYSTALLIZATION; DIFFERENTIAL SCANNING CALORIMETRY; DRUG FORMULATION; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; KARL FISCHER TITRIMETRY; LOW TEMPERATURE; MECHANICAL STRESS; MELTING POINT; MONITORING; PHASE TRANSITION; PRINCIPAL COMPONENT ANALYSIS; PRIORITY JOURNAL; RAMAN SPECTROMETRY; ROOM TEMPERATURE; SCANNING ELECTRON MICROSCOPY; SOLID STATE; STRUCTURE ANALYSIS; THERMOGRAVIMETRY; TITRIMETRY; X RAY POWDER DIFFRACTION;

CALORIMETRY, DIFFERENTIAL SCANNING; CHEMISTRY, PHARMACEUTICAL; CRYSTALLIZATION; PHASE TRANSITION; PIROXICAM; PRINCIPAL COMPONENT ANALYSIS; SPECTRUM ANALYSIS, RAMAN; TEMPERATURE; THERMOGRAVIMETRY; X-RAY DIFFRACTION;

EID: 79959584040     PISSN: 09280987     EISSN: 18790720     Source Type: Journal    
DOI: 10.1016/j.ejps.2011.05.001     Document Type: Article

References (35)

1. F.H. Allen The Cambridge Structural Database: a quarter of a million crystal structures and rising Acta Crystallogr. B58 2002 380 388 (Pubitemid 135702674)
2. Beebe, K.R., Pell, R.J., Seasholtz, M.B., 1998. Chemometrics. A Practical Quide, first ed., John Wiley and Sons, Inc., New York.
3. 2O Acta Crystallogr. C40 1984 989 990
4. H.G. Brittain Effects of mechanical processing on phase composition J. Pharm. Sci. 91 2002 1573 1580 (Pubitemid 34680220)
5. H.G. Brittain, and E.F. Fiese Effects of pharmaceutical processing on drug polymorphs and solvates H.G. Brittain, Polymorphism in Pharmaceutical Solids 1999 Marcel Dekker New York 331 361
6. K.J. Crowley, and G. Zografi Cryogenic grinding of indomethacin polymorphs and solvates: assessment of amorphous phase formation and amorphous phase physical stability J. Pharm. Sci. 91 2002 492 507 (Pubitemid 34139812)
7. g J. Pharm. Sci. 96 2007 1398 1407 (Pubitemid 46797497)
8. V.A. Drebushchak, T.P. Shakhtshneider, S.A. Apenina, A.S. Medvedeva, L.P. Safronova, and V.V. Boldyrev Thermoanalytical investigation of drug-excipient interaction. Part II. Activated mixtures of piroxicam with cellulose and chitosan J. Therm. Anal. Calorim. 86 2006 303 309 (Pubitemid 44570123)
9. N. Dujardin, J.F. Willart, E. Dudognon, A. Hedoux, Y. Guinet, L. Paccou, B. Chazallon, and M. Descamps Solid state vitrification of crystalline α and β-d-glucose by mechanical milling Solid State Commun. 148 2008 78 82
10. K.A. Graeser, C.J. Strachan, J.E. Patterson, K.C. Gordon, and T. Rades Physicochemical properties and stability of two differently prepared amorphous forms of simvastatin Cryst. Growth Des. 8 2008 128 135
11. B.C. Hancock Estimating the critical molecular mobility temperature (Tk) of amorphous pharmaceuticals Pharm. Res. 15 1998 1649 1651 (Pubitemid 28524571)
12. B.C. Hancock, and G. Zografi Characteristics and significance of the amorphous state in pharmaceutical systems J. Pharm. Sci. 86 1997 1 12
13. A.C. Jørgensen, I. Miroshnyk, M. Karjalainen, K. Jouppila, S. Siiriä, O. Antikainen, and J. Rantanen Multivariate data analysis as a fast tool in evaluation of solid state phenomena J. Pharm. Sci. 95 2006 906 916
14. W. Kauzmann The nature of the glassy state and the behavior of liquids at low temperatures Chem. Rev. 43 1948 219 256
15. K. Kogermann, J. Aaltonen, C.J. Strachan, K. Pöllänen, P. Veski, J. Heinämäki, J. Yliruusi, and J. Rantanen Qualitative in situ analysis of multiple solid-state forms using spectroscopy and partial least squares discriminant modeling J. Pharm. Sci. 96 2007 1802 1820 (Pubitemid 47122957)
16. K. Kogermann, J.A. Zeitler, J. Rantanen, T. Rades, P.F. Taday, M. Pepper, J. Heinämäki, and C.J. Strachan Investigating dehydration from compacts using terahertz pulsed, Raman and near-infrared spectroscopy Appl. Spectrosc. 61 2007 1265 1274 (Pubitemid 351189512)
17. B. Kojic-Prodic, and Z. Ruzic-Toros Structure of piroxicam Acta Crystallogr. B38 1982 2948
18. C. Lefebvre, A.M. Guyot-Hermann, M. Draguet-Brughmans, R. Bouche, and J.C. Guyot Polymorphic transitions of carbamazepine during grinding and compression Drug Dev. Ind. Pharm. 12 1986 1913 1927 (Pubitemid 17178854)
19. M. Otsuka, and T.K.N. Masumoto Effect of environmental temperature on polymorphic solid-state transformation of indomethacin during grinding Chem. Pharm. Bull. 34 1986 1784 1793 (Pubitemid 16118546)
20. M. Otsuka, T. Ofusa, and Y. Matsuda Effect of environmental humidity on the transformation pathway of carbamazepine polymorphic modifications during grinding Colloid Surface B 13 1999 263 273 (Pubitemid 29246070)
21. J.E. Patterson, M.B. James, A.H. Forster, R.W. Lancaster, J.M. Butler, and T. Rades The influence of thermal and mechanical preparative techniques on the amorphous state of four poorly soluble compounds J. Pharm. Sci. 94 2005 1998 2012 (Pubitemid 41551483)
22. O. Planinšek, J. Zadnik, M. Kunaver, S. Srčič, and A. Godec Structural evolution of indomethacin particles upon milling: time-resolved quantification and localization of disordered structure studied by IGC and DSC J. Pharm. Sci. 99 2010 1968 1981
23. G. Reck, G. Dietz, G. Laban, W. Günther, G. Bannier, and E. Höhne X-ray studies on piroxicam modifications Pharmazie 43 1988 477 481
24. E. Redenti, T. Peveri, M. Zanol, P. Ventura, G. Gnappi, and A. Montenero A study on the differentiation between amorphous piroxicam: ß-cyclodextrin complex and a mixture of the two amorphous components Int. J. Pharm. 129 1996 289 294
25. T.P. Shakhtshneider, F. Danéde, F. Capet, J.F. Willart, M. Descamps, S.A. Myz, E.V. Boldyreva, and V.V. Boldyrev Grinding of drugs with pharmaceutical excipients at cryogenic temperatures. Part I. Cryogenic grinding of piroxicam-polyvinylpyrrolidone mixtures J. Therm. Anal. Cal. 89 2007 699 707 (Pubitemid 47351761)
26. E.Y. Shalaev, and G. Zografi How does residual water affect the solid-state degradation of drugs in the amorphous state? J. Pharm. Sci. 85 1996 1137 1141 (Pubitemid 26372881)
27. A.R. Sheth, S. Bates, F.X. Muller, and D.J.W. Grant Local structure in amorphous phases of piroxicam from powder X-ray diffractometry Cryst. Growth Des. 5 2004 571 578
28. A.R. Sheth, S. Bates, F.X. Muller, and D.J.W. Grant Polymorphism in piroxicam Cryst. Growth Des. 4 2004 1091 1098 (Pubitemid 39531985)
29. A.R. Sheth, D. Zhou, F.X. Muller, and D.J.W. Grant Dehydration kinetics of piroxicam monohydrate and relationship to lattice energy and structure J. Pharm. Sci. 93 2004 3013 3026 (Pubitemid 39657805)
30. R. Surana, A. Pyne, and R. Suryanarayanan Effect of preparation method on physical properties of amorphous trehalose Pharm. Res. 21 2004 1167 1176 (Pubitemid 38960768)
31. C. Suryanarayana Mechanical alloying and milling Prog. Mater. Sci. 46 2001 1 184 (Pubitemid 32071564)
32. G.Z.Z. Zhang, D. Law, E.A. Schmitt, and Y. Qiu Phase transformation considerations during process development and manufacture of solid oral dosage forms Adv. Drug Deliv. Rev. 56 2004 371 390 (Pubitemid 38202329)
33. J.F. Willart, V. Caron, and M. Descamps Transformations of crystalline sugars upon milling J. Therm. Anal. Cal. 90 2007 125 130 (Pubitemid 47462409)
34. J.F. Willart, and M. Descamps Solid state amorphization of pharmaceuticals Mol. Pharm. 5 2008 905 920
35. F. Vrečer, M. Vrbinc, and A. Meden Characterization of piroxicam crystal modifications Int. J. Pharm. 256 2003 3 15 (Pubitemid 36412135)